<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Geuka Africa | Alberta Boucaut | Activity</title>
	<link>https://geuka.org/members/albertaboucaut7/activity/</link>
	<atom:link href="https://geuka.org/members/albertaboucaut7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Alberta Boucaut.</description>
	<lastBuildDate>Tue, 02 Jun 2026 11:09:28 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">72b899b5ddc4ba2211a25062f8e48f62</guid>
				<title>Alberta Boucaut started the topic 4FADB,4F-ADB, in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/4fadb4f-adb-3/</link>
				<pubDate>Sun, 31 May 2026 20:01:30 +0000</pubDate>

									<content:encoded><![CDATA[<p>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis&hellip;<span class="activity-read-more" id="activity-read-more-205715"><a href="https://geuka.org/forums/topic/4fadb4f-adb-3/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2824244c3441ae1a742e53d704ebfe8a</guid>
				<title>Alberta Boucaut started the topic 5F-ADB-PINACA Wikipedia in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/5f-adb-pinaca-wikipedia-4/</link>
				<pubDate>Sun, 31 May 2026 19:58:15 +0000</pubDate>

									<content:encoded><![CDATA[<p>Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the&hellip;<span class="activity-read-more" id="activity-read-more-205713"><a href="https://geuka.org/forums/topic/5f-adb-pinaca-wikipedia-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ae0b85a7d127f2f0c6fe9b80285bfbdc</guid>
				<title>Alberta Boucaut started the topic Involuntary intoxication caused by vaping the synthetic cannabinoid. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/involuntary-intoxication-caused-by-vaping-the-synthetic-cannabinoid-6/</link>
				<pubDate>Sun, 31 May 2026 19:52:30 +0000</pubDate>

									<content:encoded><![CDATA[<p>Legal status<br />
Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some&hellip;<span class="activity-read-more" id="activity-read-more-205708"><a href="https://geuka.org/forums/topic/involuntary-intoxication-caused-by-vaping-the-synthetic-cannabinoid-6/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d333276bdbc9b7b08e1f4dccba482483</guid>
				<title>Alberta Boucaut started the topic Clinical features associated with ADB-BUTINACA exposure in patients attending. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-4/</link>
				<pubDate>Sun, 31 May 2026 19:40:35 +0000</pubDate>

									<content:encoded><![CDATA[<p>Figure 1.<br />
Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as&hellip;<span class="activity-read-more" id="activity-read-more-205697"><a href="https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">91acf0001f0ceaae4fd20a6d66ac6b4c</guid>
				<title>Alberta Boucaut started the topic 4F-MDMB-BINACA in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/4f-mdmb-binaca/</link>
				<pubDate>Tue, 26 May 2026 07:38:33 +0000</pubDate>

									<content:encoded><![CDATA[<p>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the adb butinaca JWH-210 (5 mg/kg, i.p.) treated group showed&hellip;<span class="activity-read-more" id="activity-read-more-204429"><a href="https://geuka.org/forums/topic/4f-mdmb-binaca/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>